Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Gepotidacin in Healthy Adults and Adolescents
NCT04079790Phase 1Completed
- Sponsor
- GSK
- Start
- Sep 2019
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of gepotidacin in bacterial infection (4 arms), sponsored by GSK. Primary endpoints: Area Under the Concentration-time Curve From Time 0 to Last Quantifiable Concentration, Area Under the Concentration-time Curve From Time 0 Extrapolated to Infinite Time and 13 more. Started Sep 2019; status: completed.
02
Drugs
gepotidacin
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT04079790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04079790.